LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Canertinib | 0.37 | uM | LJP6 | 1 | H10 | 72 | hr | 929 | 3162 | 3228 | 0.9795 | 0.9713 |
Hs 578T | Canertinib | 0.37 | uM | LJP6 | 2 | H10 | 72 | hr | 929 | 3101 | 3228 | 0.9606 | 0.9447 |
Hs 578T | Canertinib | 0.37 | uM | LJP6 | 3 | H10 | 72 | hr | 929 | 3106 | 3228 | 0.9622 | 0.9469 |
Hs 578T | Celastrol | 0.37 | uM | LJP6 | 1 | G10 | 72 | hr | 929 | 2663 | 3228 | 0.8250 | 0.7542 |
Hs 578T | Celastrol | 0.37 | uM | LJP6 | 2 | G10 | 72 | hr | 929 | 2713 | 3228 | 0.8404 | 0.7759 |
Hs 578T | Celastrol | 0.37 | uM | LJP6 | 3 | G10 | 72 | hr | 929 | 2830 | 3228 | 0.8767 | 0.8268 |
Hs 578T | CGP60474 | 0.37 | uM | LJP5 | 1 | F04 | 72 | hr | 929 | 788 | 3228 | 0.2441 | -0.0614 |
Hs 578T | CGP60474 | 0.37 | uM | LJP5 | 2 | F04 | 72 | hr | 929 | 940 | 3228 | 0.2912 | 0.0047 |
Hs 578T | CGP60474 | 0.37 | uM | LJP5 | 3 | F04 | 72 | hr | 929 | 784 | 3228 | 0.2429 | -0.0632 |
Hs 578T | CGP60474 | 0.37 | uM | LJP6 | 1 | G04 | 72 | hr | 929 | 863 | 3228 | 0.2673 | -0.0288 |
Hs 578T | CGP60474 | 0.37 | uM | LJP6 | 2 | G04 | 72 | hr | 929 | 784 | 3228 | 0.2429 | -0.0632 |
Hs 578T | CGP60474 | 0.37 | uM | LJP6 | 3 | G04 | 72 | hr | 929 | 901 | 3228 | 0.2791 | -0.0123 |
Hs 578T | CHIR-99021 | 0.37 | uM | LJP6 | 1 | P16 | 72 | hr | 929 | 2915 | 3228 | 0.9030 | 0.8638 |
Hs 578T | CHIR-99021 | 0.37 | uM | LJP6 | 2 | P16 | 72 | hr | 929 | 3171 | 3228 | 0.9823 | 0.9752 |
Hs 578T | CHIR-99021 | 0.37 | uM | LJP6 | 3 | P16 | 72 | hr | 929 | 3174 | 3228 | 0.9833 | 0.9765 |
Hs 578T | CP724714 | 0.37 | uM | LJP5 | 1 | A10 | 72 | hr | 929 | 2960 | 3228 | 0.9170 | 0.8834 |
Hs 578T | CP724714 | 0.37 | uM | LJP5 | 2 | A10 | 72 | hr | 929 | 3093 | 3228 | 0.9582 | 0.9413 |
Hs 578T | CP724714 | 0.37 | uM | LJP5 | 3 | A10 | 72 | hr | 929 | 3208 | 3228 | 0.9938 | 0.9913 |
Hs 578T | CP466722 | 0.37 | uM | LJP5 | 1 | I10 | 72 | hr | 929 | 3397 | 3228 | 1.0523 | 1.0735 |
Hs 578T | CP466722 | 0.37 | uM | LJP5 | 2 | I10 | 72 | hr | 929 | 3437 | 3228 | 1.0647 | 1.0909 |
Hs 578T | CP466722 | 0.37 | uM | LJP5 | 3 | I10 | 72 | hr | 929 | 3511 | 3228 | 1.0876 | 1.1231 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 1 | A22 | 72 | hr | 929 | 2965 | 3228 | 0.9185 | 0.8856 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 2 | A22 | 72 | hr | 929 | 2928 | 3228 | 0.9071 | 0.8695 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 3 | A22 | 72 | hr | 929 | 3069 | 3228 | 0.9507 | 0.9308 |
Hs 578T | Momelotinib | 0.37 | uM | LJP5 | 1 | P10 | 72 | hr | 929 | 2520 | 3228 | 0.7807 | 0.6920 |